Holding / family officeRegistered location :Geneva

RELIEF THERAPEUTICS Holding SADeclared Swiss shareholdings

RELIEF THERAPEUTICS Holding SA: 1 Swiss companies with a declared holding, including MindMaze Therapeutics Holding SA. Latest filing: 05.05.2023.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
1
Largest position
76,56 %
MindMaze Therapeutics Holding SA
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
05.05.2023
Active since 2020

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held
How to read these figures?

Rates come from the 31 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controls

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 6

90 days · Downward crossings

0

visible history: 23

First disclosure: 19.08.2020Last disclosure: 05.05.2023

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
22
Sale positions
435

Latest shareholding disclosures

Show 26 older disclosures
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

57.002%Voting rights sold14.12.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

59.351%Voting rights sold10.11.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

65.491%Voting rights sold25.10.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

67.543%Voting rights sold13.10.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

58.283%Voting rights sold08.07.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

58.283%Voting rights sold08.07.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

59.772%Voting rights sold05.07.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

37.039%Voting rights sold04.05.2022
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

28.136%Voting rights sold04.12.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

22.57%Voting rights sold04.11.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

13.065%Voting rights acquired04.09.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

22.726%Voting rights acquired31.07.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

19.641%Voting rights acquired31.07.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

13.318%Voting rights acquired31.07.2021
PurchaseShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

29.41%Voting rights acquired27.07.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

21.104%Voting rights sold07.05.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

9.904%Voting rights sold16.03.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

8.781%Voting rights sold09.03.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

4.151%Voting rights sold26.01.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

9.676%Voting rights sold26.01.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

7.372%Voting rights sold26.01.2021
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

0.952%Voting rights sold02.12.2020
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

4.371%Voting rights sold14.11.2020
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

24.098%Voting rights sold20.10.2020
SaleShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

31.49%Voting rights sold29.08.2020
PurchaseShareholdings

MindMaze Therapeutics Holding SA

RELIEF THERAPEUTICS Holding SA · Single shareholder

0.189%Voting rights acquired19.08.2020

insider24.ch

Follow RELIEF THERAPEUTICS Holding SA’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in RELIEF THERAPEUTICS Holding SA’s disclosed portfolio?

    MindMaze Therapeutics Holding SA.

    What is RELIEF THERAPEUTICS Holding SA’s latest disclosure?

    The latest available disclosure was published on 05.05.2023 and concerns MindMaze Therapeutics Holding SA. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.